The presence of very low levels of residues (including solvents) in excipients is becoming an important issue for users, and the presence of very low levels of ?non-lactose? species in DPI lactose may pose challenges to suppliers and users.
J. Sebastian Kærger
Advertisement
Articles by J. Sebastian Kærger
Advertisement
Latest Updated Articles
Carriers for DPIs: formulation and regulatory challengesPublished: October 1st 2006 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmTech Weekly News Roundup – Week of November 3, 2025
2
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
2025 AAPS PharmSci 360 to Highlight Next-Gen AI for Drug Development
5
